Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

Related Articles by Review for PubMed (Select 23087183)

1.

Efficacy of anti-IL-1 treatment in Majeed syndrome.

Herlin T, Fiirgaard B, Bjerre M, Kerndrup G, Hasle H, Bing X, Ferguson PJ.

Ann Rheum Dis. 2013 Mar;72(3):410-3. doi: 10.1136/annrheumdis-2012-201818. Epub 2012 Oct 20.

2.

Autoinflammatory bone disorders: update on immunologic abnormalities and clues about possible triggers.

Sharma M, Ferguson PJ.

Curr Opin Rheumatol. 2013 Sep;25(5):658-64. doi: 10.1097/BOR.0b013e328363eb08. Review.

PMID:
23917160
3.

[New drugs and treatment strategies for rheumatoid arthritis].

Fantini F.

Recenti Prog Med. 2003 Sep;94(9):361-79. Review. Italian.

PMID:
12942798
4.

Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.

Kötter I, Wacker A, Koch S, Henes J, Richter C, Engel A, Günaydin I, Kanz L.

Semin Arthritis Rheum. 2007 Dec;37(3):189-97. Epub 2007 Jun 20. Review.

PMID:
17583775
5.

Autoinflammatory bone diseases.

Stern SM, Ferguson PJ.

Rheum Dis Clin North Am. 2013 Nov;39(4):735-49. doi: 10.1016/j.rdc.2013.05.002. Epub 2013 Aug 17. Review.

6.

Autoinflammatory bone disorders.

Morbach H, Hedrich CM, Beer M, Girschick HJ.

Clin Immunol. 2013 Jun;147(3):185-96. doi: 10.1016/j.clim.2012.12.012. Epub 2013 Jan 5. Review.

PMID:
23369460
7.

Majeed Syndrome.

El-Shanti H, Ferguson P.

In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015.
2008 Sep 23 [updated 2013 Mar 14].

8.

[Indications and modes of use for interleukin (IL)-1 antagonists in inflammatory dermatosis: a new therapeutic approach to immune-mediated inflammatory diseases].

Lipsker D, Lenormand C.

Ann Dermatol Venereol. 2012 Jun;139(6-7):459-67. doi: 10.1016/j.annder.2012.03.012. Epub 2012 Apr 17. Review. French.

PMID:
22721478
9.

Actual status of antiinterleukin-1 therapies in rheumatic diseases.

Geyer M, Müller-Ladner U.

Curr Opin Rheumatol. 2010 May;22(3):246-51. doi: 10.1097/BOR.0b013e3283373fa0. Review.

PMID:
20150813
10.

Biological response modifiers in the management of rheumatoid arthritis.

Louie SG, Park B, Yoon H.

Am J Health Syst Pharm. 2003 Feb 15;60(4):346-55. Review. Erratum in: Am J Health Syst Pharm.2003 Jun 1;60(11):1095.

PMID:
12625216
11.

Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives.

Cantarini L, Lucherini OM, Muscari I, Frediani B, Galeazzi M, Brizi MG, Simonini G, Cimaz R.

Autoimmun Rev. 2012 Nov;12(1):38-43. doi: 10.1016/j.autrev.2012.07.020. Epub 2012 Aug 2. Review.

PMID:
22884554
12.

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.

Dinarello CA, Simon A, van der Meer JW.

Nat Rev Drug Discov. 2012 Aug;11(8):633-52. doi: 10.1038/nrd3800. Review.

13.

Molecular differences in anticytokine therapies.

Calabrese LH.

Clin Exp Rheumatol. 2003 Mar-Apr;21(2):241-8. Review.

PMID:
12747285
14.

Biological treatment in adult-onset Still's disease.

Pouchot J, Arlet JB.

Best Pract Res Clin Rheumatol. 2012 Aug;26(4):477-87. doi: 10.1016/j.berh.2012.07.002. Review.

PMID:
23040362
15.

Chronic recurrent multifocal osteomyelitis: a concise review and genetic update.

El-Shanti HI, Ferguson PJ.

Clin Orthop Relat Res. 2007 Sep;462:11-9. Review.

PMID:
17496555
16.

Biologic therapy for rheumatoid arthritis: clinical efficacy and predictors of response.

Gibbons LJ, Hyrich KL.

BioDrugs. 2009;23(2):111-24. doi: 10.2165/00063030-200923020-00004. Review.

PMID:
19489652
17.

Autoinflammatory bone disorders.

Ferguson PJ, El-Shanti HI.

Curr Opin Rheumatol. 2007 Sep;19(5):492-8. Review.

PMID:
17762617
18.

Why not treat human cancer with interleukin-1 blockade?

Dinarello CA.

Cancer Metastasis Rev. 2010 Jun;29(2):317-29. doi: 10.1007/s10555-010-9229-0. Review.

19.

The role of interleukin-1 in bone resorption in rheumatoid arthritis.

Strand V, Kavanaugh AF.

Rheumatology (Oxford). 2004 Jun;43 Suppl 3:iii10-iii16. Review.

20.

The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis.

Kalliolias GD, Liossis SN.

Expert Opin Investig Drugs. 2008 Mar;17(3):349-59. doi: 10.1517/13543784.17.3.349 . Review.

PMID:
18321234
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk